12 drug(s) with this reaction
4,726 total reports
Migraine has been reported as an adverse reaction across 12 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 4,726 adverse event reports mention migraine in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with migraine, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have migraine listed in their FDA adverse event reports, sorted by report count:
In addition to migraine, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
12 drug(s) manufactured by Haleon Us Holdings Llc have migraine listed in their FDA adverse event reports: FLUTICASONE PROPIONATE, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE, IBUPROFEN SODIUM, and others.
There are a combined 4,726 reports of migraine across 12 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.